In Vitro Maturation of Human Eggs

Description

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication

Conditions

Healthy, PCOS, PCOS (Polycystic Ovary Syndrome), Ovarian Reserve, Infertility, Infertility Female, Infertility of Tubal Origin, Infertility Poly Cystic Ovary, AMH, In Vitro Maturation, IVM, IVF

Talk to us

Study Overview

On this page

Study Details

Study overview

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication

In Vitro Maturation of Human Eggs

In Vitro Maturation of Human Eggs

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Lone Tree

Colorado Center for Reproductive Medicine, Lone Tree, Colorado, United States, 80124

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infertile women diagnosed with PCOS or polycystic ovaries, or infertile women with good ovarian reserve
  • * Antral follicle count (AFC) greater than 24
  • * AMH greater than 3.5 ng/ml
  • * Body Mass Index less than 35
  • * Accept to have embryos biopsied for PGT
  • * Intend to perform embryo transfer within 4 months after completing the IVM cycle
  • * Paternal (or donor) age \<45, ejaculated sperm collection only (partner frozen and donor sperm acceptable), sperm morphology (strict criteria) \>1%, motility \> 20% and sperm count \> 10 million per ml (so samples can be prepared through standard procedure)
  • * More than 2 failed IVF cycles

Ages Eligible for Study

to 38 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Colorado Center for Reproductive Medicine,

Study Record Dates

2030-08-30